|
|
(21 intermediate revisions by 3 users not shown) |
Line 1: |
Line 1: |
| <StructureSection load='4bw2' size='340' side='right' caption='Human bromodomain-containing protein 4 bromodomain 1 complex with inhibitor (PDB code [[4bw2]])' scene=''> | | <StructureSection load='' size='350' side='right' caption='Human bromodomain-containing protein 4 bromodomain 1 complex with inhibitor and ethylene glycol (PDB code [[3p5o]])' scene='72/724778/Cv/1'> |
| == Function == | | == Function == |
|
| |
|
| '''Bromodomain-containing proteins''' (BRD) are active as histone acetyltransferase, chromatin remodeling and transcriptional mediation. The bromodomain is a ca. 110 amino acid long sequence which recognizes acetylated lysine residues which are found in the C-terminal of histones. | | '''Bromodomain-containing proteins''' (BRD) are active as histone acetyltransferase, chromatin remodeling and transcriptional mediation. The bromodomain is a ca. 110 amino acid long sequence which recognizes acetylated lysine residues which are found in the C-terminal of histones<ref>PMID:11911891</ref>. |
| <ref>PMID:21638687</ref> to the rescue. | | *'''BRD1''' is essential for normal brain development<ref>PMID:35941107</ref>. |
| For detalis on BRD3 see [[Human bromodomain containing protein 3]] | | *'''BRD2''' promotes spatial mixing and compartmentalisation of chromatin<ref>PMID:35410381</ref>. |
| | *'''BRD3''' and '''BRD4''' regulate skeletal myogenesis<ref>PMID:28733670</ref>. For detalis on BRD3 see [[Human bromodomain containing protein 3]] |
| | *'''BRD7''' promotes colorectal cancer by regulating the ubiquitin-proteasome-dependent stabilisation of c-Myc protein<ref>PMID:34109174</ref>. |
| | *'''BRD9''' has a role in activation of interferon-stimulated genes<ref>PMID:34983841</ref>. |
|
| |
|
| == Disease == | | == Disease == |
|
| |
|
| Dysfunction of BRD is involved in cancer, inflammation and multiple sclerosis. | | Dysfunction of BRD is involved in cancer, inflammation, obesity and multiple sclerosis<ref>PMID:22722403</ref>. BRD4 translocations are detected in NUT midline carcinoma and a variety of BRD4 inhibitors are clinically tested at the present<ref>PMID:18552174</ref>. |
| | |
| == Relevance ==
| |
|
| |
|
| == Structural highlights == | | == Structural highlights == |
|
| |
|
| </StructureSection> | | <scene name='72/724778/Cv/4'>BRD4 bromodomain 1 inhibitors bind to the acetyl-binding pocket</scene><ref>PMID:18552174</ref>. Water molecules are shown as red spheres. |
| == 3D Structures of bromodomain-containing protein ==
| |
| | |
| Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| |
| {{#tree:id=OrganizedByTopic|openlevels=0|
| |
|
| |
|
| *Bromodomain-containing protein 1
| |
|
| |
| **[[3lyi]] – hBRD1 PWWP domain - human<br />
| |
| **[[2ku3]] – hBRD1 PHD1 zinc finger domain - NMR<br />
| |
| **[[2lq6]] – hBRD1 PHD2 zinc finger domain (mutant) - NMR<br />
| |
| **[[3l43]] – histone H3.3 N-terminal/hBRD1 PHD1 zinc finger domain - NMR<br />
| |
| **[[3rcw]] – hBRD1 bromodomain <br />
| |
| **[[5ame]] – hBRD1 bromodomain+PHD (mutant) + piperazine derivative<br />
| |
| **[[5amf]] – hBRD1 bromodomain+PHD (mutant) + indazole derivative<br />
| |
| **[[5fg6]] – hBRD1 bromodomain+PHD + probe<br />
| |
| **[[4z02]] – hBRD1 residues 925-1049 + quinoline derivative<br />
| |
|
| |
| *Bromodomain-containing protein 2
| |
|
| |
| **[[1x0j]], [[2dvv]] – hBRD2 N-terminal bromodomain <br />
| |
| **[[5hel]], [[5hem]], [[5hen]], [[5hfq]] – hBRD2 N-terminal bromodomain (mutant)<br />
| |
| **[[2g4a]] – hBRD2 residues 1-116 - NMR<br />
| |
| **[[4qeu]], [[5dfb]] – hBRD2 bromodomain 2 (mutant)<br />
| |
|
| |
| *Bromodomain-containing protein 2 complex
| |
|
| |
| **[[2dvq]], [[2dvr]], [[2dvs]], [[2e3k]] – hBRD2 N-terminal bromodomain + histone H4 peptide<br />
| |
| **[[3oni]] – hBRD2 residues 224-335 + inhibitor<br />
| |
| **[[3aqa]], [[2ydw]], [[2yek]], [[4a9e]], [[4a9f]], [[4a9h]], [[4a9i]], [[4a9j]], [[4a9m]], [[4a9n]], [[4a9o]], [[4alh]], [[4akn]], [[4alg]], [[4uyf]], [[4uyg]], [[4uyh]] – hBRD2 N-terminal bromodomain + inhibitor<br />
| |
| **[[4mr5]], [[4mr6]], [[4j1p]] – hBRD2 bromodomain 2 + inhibitor<br />
| |
| **[[5bt5]] – hBRD2 bromodomain 2 + probe<br />
| |
| **[[4qev]], [[4qew]] – hBRD2 bromodomain 2 (mutant) + probe<br />
| |
| **[[5dfc]], [[5dfd]] – hBRD2 bromodomain 2 (mutant) + ligand<br />
| |
|
| |
| *Bromodomain-containing protein 3
| |
|
| |
| **[[2nxb]] – hBRD3 bromodomain 1<br />
| |
| **[[2yw5]] – hBRD3 bromodomain 1 - NMR<br />
| |
| **[[3s91]], [[3s92]] – hBRD3 bromodomain 1 + inhibitor<br />
| |
| **[[2l5e]] – mBRD3 bromodomain 1 + GATA-1 C-terminal – mouse - NMR<br />
| |
| **[[2oo1]] – hBRD3 bromodomain 2<br />
| |
| **[[2e7n]] – hBRD3 bromodomain 2 - NMR<br />
| |
| **[[5hfr]] – hBRD3 bromodomain 2 (mutant)<br />
| |
|
| |
| *Bromodomain-containing protein 4
| |
|
| |
| **[[2oss]], [[4j3i]], [[4lyi]] – hBRD4 bromodomain 1<br />
| |
| **[[2ouo]] – hBRD4 bromodomain 2<br />
| |
| **[[2i8n]] – hBRD4 bromodomain 2 - NMR<br />
| |
| **[[3jvj]] – mBRD4 bromodomain 1<br />
| |
| **[[2dww]], [[3jvl]], [[3jvm]] – mBRD4 bromodomain 2<br />
| |
| **[[2jns]] – mBRD4 ET domain - NMR<br />
| |
|
| |
| *Bromodomain-containing protein 4 bromodomain 1 complex
| |
|
| |
| **[[3jvk]], [[3muk]], [[3mul]] – mBRD4 bromodomain 1 + histone H3.3 peptide<br />
| |
| **[[3uvw]], [[3uvy]], [[3uvx]], [[3uw9]] – hBRD4 bromodomain 1 + histone H4 peptide<br />
| |
| **[[4kv1]] – hBRD4 bromodomain 1 + Rel peptide<br />
| |
| **[[3mxf]] – mBRD4 bromodomain 1 + inhibitor<br />
| |
| **[[3p5o]], [[2yel]], [[3zyu]], [[3u5j]], [[3u5k]], [[4a9l]], [[4e96]], [[4f3i]], [[4hxk]], [[4hxl]], [[4hxm]], [[4hxn]], [[4hxo]], [[4hxp]], [[4hxr]], [[4hxs]], [[4lr6]], [[4lrg]], [[3svf]], [[3svg]], [[4gpj]], [[4hbv]], [[4hbw]], [[4hbx]], [[4hby]], [[4don]], [[4j0r]], [[4j0s]], [[4bw1]], [[4bw2]], [[4bw3]], [[4bw4]], [[4men]], [[4meo]], [[4mep]], [[4meq]], [[4bjx]], [[4c66]], [[4c67]], [[4ioo]], [[4ioq]], [[4ior]], [[4mr3]], [[4mr4]], [[4nqm]], [[4nr8]], [[4cfk]], [[4cfl]], [[4lyw]], [[4ogi]], [[4ogj]], [[4o70]], [[4o71]], [[4o72]], [[4o74]], [[4o75]], [[4o76]], [[4o77]], [[4o78]], [[4o7a]], [[4o7b]], [[4o7c]], [[4o7e]], [[4o7f]], [[4ps5]], [[4nuc]], [[4nue]], [[4nud]], [[4pce]], [[4pci]], [[4uyd]], [[4qzs]], [[4wiv]], [[4cl9]], [[4clb]], [[4xy9]], [[4xya]], [[4z1q]], [[4z1s]], [[4uix]], [[4uiy]], [[4uiz]], [[4qr3]], [[4qr4]], [[4qr5]], [[5bt4]], [[5a5s]], [[5a85]], [[5acy]], [[4x2i]], [[4zc9]], [[5fbx]], [[4yh3]], [[4yh4]], [[5coi]], [[5cp5]], [[5cpe]], [[5cqt]], [[5crm]], [[5crz]], [[5cs8]], [[5ctl]], [[5cy9]], [[5d0c]], [[5dx4]], [[4lzs]], [[5d24]], [[5d25]], [[5d26]], [[5d3h]], [[5d3j]], [[5d3l]], [[5d3n]], [[5d3p]], [[5d3r]], [[5d3s]], [[5d3t]], [[5egu]], [[5ei4]], [[5eis]], [[5hls]], [[5hm0]] – hBRD4 bromodomain 1 + inhibitor<br />
| |
| **[[4lys]], [[4lzr]] – hBRD4 bromodomain 1 + colchiceine<br />
| |
| **[[4qb3]] – hBRD4 bromodomain 1 + olinone<br />
| |
| **[[4whw]] – hBRD4 bromodomain 1 + probe<br />
| |
|
| |
| *Bromodomain-containing protein 4 bromodomain 2 complex
| |
|
| |
| **[[2yem]], [[4z93]] – hBRD4 bromodomain 2 + inhibitor<br />
| |
| **[[2lsp]] – hBRD4 bromodomain 2 + Nf-Kb peptide<br />
| |
| **[[4kv4]] – hBRD4 bromodomain 2 + Rel peptide<br />
| |
| **[[2mjv]] – hBRD4 bromodomain 2 + Twist peptide<br />
| |
|
| |
| *Bromodomain-containing protein 9
| |
|
| |
| **[[3hme]] – hBRD9 bromodomain <br />
| |
| **[[4nqn]], [[4xy8]], [[4z6h]], [[4z6i]], [[5e9v]] – hBRD9 bromodomain + inhibitor<br />
| |
| **[[4yy4]] – hBRD9 bromodomain + DMSO<br />
| |
| **[[4yy6]], [[4yyd]], [[4yyg]], [[4yyh]], [[4yyj]], [[4yyk]] – hBRD9 bromodomain + histone H4 peptide<br />
| |
| **[[4uit]], [[4uiu]], [[4uiv]], [[4uiw]] – hBRD9 N-terminal bromodomain + inhibitor<br />
| |
| }}
| |
|
| |
|
| | == 3D Structures of bromodomain-containing protein == |
| | [[Bromodomain-containing protein 3D structures]] |
|
| |
|
| | </StructureSection> |
|
| |
|
| == References == | | == References == |
| <references/> | | <references/> |
| | [[Category:Topic Page]] |